HBRD LIMITED

Company number 13976355 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

HBRD LIMITED - Analysis Report

Company Number: 13976355

Analysis Date: 2025-07-29 14:36 UTC

Financial Health Assessment of HBRD LIMITED


1. Financial Health Score: C

Explanation:
The company shows a stable asset base with significant fixed investments but suffers from weak liquidity and working capital issues. While the net assets are positive and stable, the negative net current assets and high short-term liabilities indicate symptoms of financial strain that need addressing to improve overall health.


2. Key Vital Signs

Metric Value (31 March 2024) Interpretation
Fixed Assets £880,460 Strong investment in long-term assets; "healthy bone structure" of the company.
Current Assets £46,085 Very low relative to liabilities, indicating "weak pulse" in short-term liquidity.
Current Liabilities £491,436 High short-term obligations; "heavy burden" on immediate financial resources.
Net Current Assets (Working Capital) -£445,351 Negative working capital signals "symptoms of distress" in meeting short-term debts.
Net Assets (Shareholders’ Funds) £435,109 Positive but largely reflects fixed assets rather than liquid resources; "solid skeleton" but fragile.
Share Capital £1.00 Minimal equity capital; company relies on reserves/share premium for financial foundation.
Loans to Director (Debtors) £46,095 Large loan to director is part of debtors, which may affect liquidity if not repaid promptly.

3. Diagnosis

HBRD LIMITED’s financial health presents a mixed picture. The company has a solid fixed asset base of £880,460, which constitutes its primary strength and forms the backbone of its value. However, the current assets are critically low (£46,085) compared to current liabilities (£491,436), resulting in a severely negative working capital position (-£445,351). This implies that the company may struggle to cover its short-term obligations, a classic symptom of liquidity stress.

The negative working capital is a red flag indicating potential cash flow problems, especially if creditors demand payment before the company can convert assets or receivables into cash. The net assets remain positive due to the substantial fixed assets and shareholders’ funds (£435,109), but these are less liquid and cannot be readily used to settle immediate debts.

An additional symptom is the significant loan (£46,095) to a director, which is interest-free and repayable on demand. While this might offer some flexibility, it also ties up cash that could be used to improve liquidity.

The company is classified as a private limited company engaged in "Other business support service activities not elsewhere classified". The small number of employees (average of 1) indicates a lean operation, but the financial structure suggests it is capital-intensive or investment-heavy rather than cash-generative at this stage.


4. Recommendations

To improve financial wellness and strengthen the company's health, consider the following actions:

  • Improve Liquidity and Working Capital:
    Explore ways to increase current assets—such as accelerating debtor collections or injecting working capital—to reduce the negative working capital. Negotiate longer payment terms with creditors to ease short-term cash pressure.

  • Review Director Loan:
    The sizeable director loan, while flexible, ties up cash. A repayment plan or conversion to equity could improve liquidity and reduce balance sheet risk.

  • Monitor Cash Flow Closely:
    Implement rigorous cash flow forecasting to anticipate liquidity shortages and proactively manage payables and receivables.

  • Asset Utilisation:
    Evaluate whether the fixed assets are generating sufficient returns or consider leveraging them (e.g., secured borrowing) to address liquidity gaps without compromising the company’s operational capacity.

  • Capital Structure Review:
    Given the minimal share capital, consider if a capital injection is viable to strengthen the equity base and reduce reliance on short-term financing.

  • Financial Controls and Planning:
    Establish stronger financial controls and budgeting to detect symptoms of financial distress early and take timely action.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.